MEDP Medpace Holdings, Inc.
Medpace Holdings, Inc. (MEDP) is expected to report earnings on October 21, 2026, after the market close. The consensus earnings estimate is $4.45 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -10.6% since its last earnings release on July 22, 2026.
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About Medpace Holdings, Inc.
Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries.
Sector
Healthcare
Industry
Research Services